Inicio>>Isotope-Labeled Compounds>> Deuterium>>Carazolol-d7

Carazolol-d7 (Synonyms: (±)-Carazolol-d7)

Catalog No.GC49564

An internal standard for the quantification of carazolol

Products are for research use only. Not for human use. We do not sell to patients.

Carazolol-d7 Chemical Structure

Cas No.: 1173021-02-7

Tamaño Precio Disponibilidad Cantidad
1 mg
52,00 $
Disponible
5 mg
181,00 $
Disponible
10 mg
330,00 $
Disponible
25 mg
695,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Carazolol-d7 is intended for use as an internal standard for the quantification of carazolol by GC- or LC-MS. Carazolol is a β-adrenergic receptor (β-AR) ligand (Kds = 0.2, 0.03, and 4.47 nM for the human β1-, β2-, and β3-ARs, respectively).1 It reduces epinephrine-induced increases in mean arterial blood pressure and heart rate in conscious pigs when administered at a dose of 10 µg/kg.2 Carazolol has been found in wastewater effluent.3 Formulations containing carazolol have been used to reduce stress in livestock during transport.

1.Baker, J.G.The selectivity of β-adrenoceptor agonists at human β1-, β2- and β3-adrenoceptorsBr. J. Pharmacol.160(5)1048-1061(2010) 2.Gregory, N.G., and Wilkins, L.J.The effect of carazolol on the cardiovascular responses to adrenaline in stress sensitive pigsVet. Res. Commun.5(3)277-283(1982) 3.Ternes, T.A.Occurrence of drugs in German sewage treatment plants and riversWater Res.32(11)3245-3260(1998)

Reseñas

Review for Carazolol-d7

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Carazolol-d7

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.